MizMedi Hospital

All Doctors

Departments

Select Department

Select Doctors

홈으로

Endocrinology

Dr.Kim Seong-hoon

Endocrine diseases are improved through lifestyle modification and treatment. We will understand and communicate with the patient to find management and treatment tailored to each individual.

Specialties

Diabetes, Gestational diabetes, Dyslipidemia, Thyroid disease, Osteoporosis, Endocrine diseases

Sep Oct

Schedule	Mon31	Tue1	Wed2	Thu3	Fri4	Sat5
AM
PM

Schedule	Mon7	Tue8	Wed9	Thu10	Fri11	Sat12
AM
PM

Schedule	Mon14	Tue15	Wed16	Thu17	Fri18	Sat19
AM
PM

Schedule	Mon21	Tue22	Wed23	Thu24	Fri25	Sat26
AM
PM

Schedule	Mon28	Tue29	Wed30	Thu1	Fri2	Sat3
AM
PM

Schedule	Mon5	Tue6	Wed7	Thu8	Fri9	Sat10
AM
PM

Schedule	Mon12	Tue13	Wed14	Thu15	Fri16	Sat17
AM
PM

Schedule	Mon19	Tue20	Wed21	Thu22	Fri23	Sat24
AM
PM

Schedule	Mon26	Tue27	Wed28	Thu29	Fri30	Sat31
AM
PM

Education & Experience Academic Activities

Professor at Yonsei University Wonju College of Medicine, Internal Medicine Department
Chief of Department of Internal Medicine (Endocrinology) at Seoul Red Cross Hospital
Professor of Internal Medicine at Dankook University College of Medicine Jeil Hospital
Professor of Internal Medicine at Sungkyunkwan University School of Medicine and Kwandong University College of Medicine
Internal Medicine Specialist at Jeil Hospital
Postdoctoral Research Fellow at Joslin Diabetes Center, Harvard Medical School
Specialist in Endocrinology and Metabolism at Samsung Medical Center
Specialist in Internal Medicine at Kyung Hee University Hospital
Doctorate degree in Medicine from Graduate School of Medicine, Kyung Hee University
School of Medicine, Kyung Hee University

President of the Diabetes Genetics Research Society of the Korean Diabetes Association (2021.01-)
Member of the Korean Diabetes Association
Member of the Korean Endocrinology Society
Director of the Research Committee of the Korean Obesity Society (2013.01 ~ 2014.12)
Secretary of the Insurance Committee of the Korean Endocrinology Society (2006-2010)
Secretary of the Education Committee of the Korean Internal Medicine Association (2013.12-2016.12)
Member, American Diabetes Association (ADA)
Member, European Association for the Study of Diabetes (EASD)
Association of aryl hydrocarbon receptor transactivating activity, a potential biomarker for persistent organic pollutants, with the risk of gestational diabetes mellitus. Park S, Chon S, Park SY, Yun S, Baik SH, Woo JT, Rhee SY, Pak YK, Kim SH Sci Rep. 2021 Feb 4;11(1):3185. doi: 10.1038/s41598-021-82794-0.
Self-Management Mobile Virtual Reality Program for Women with Gestational Diabetes. Int J Environ Res Public Health. Kim SH, Kim HJ, Shin G. 2021 Feb 5;18(4):1539. doi: 10.3390/ijerph18041539.
Pregnancy Outcomes of Women Additionally Diagnosed as Gestational Diabetes by the International Association of the Diabetes and Pregnancy Study Groups Criteria. Kim MH, Kwak SH, Kim SH, Hong JS, Chung HR, Choi SH, Kim MY, Jang HC. Diabetes Metab J. 2019 Dec;43(6):766-775. doi: 10.4093/dmj.2018.0192.
Maternal and neonatal outcomes in Korean women with type 2 diabetes. Jang HJ, Kim HS, Kim SH. Korean J Intern Med 2018;33:1143-1149
Dietary Patterns and Their Associations with the Diet Quality Index-International (DQI-I) in Korean Women with Gestational Diabetes Mellitus. Shin MK, Kim YS, Kim JH, Kim SH, Kim Y. Clin Nutr Res. 2015 Oct;4(4):216-224
Maturity-Onset Diabetes of the Young: What Do Clinicians Need to Know?. Kim SH. Diabetes Metab J. 2015 Dec;39(6):468-477.
Maternal and Neonatal Outcomes in Korean Women with Type 1 and Type 2 Diabetes. Kim HS, Jang HJ, Park JE, Kim MY, Ko SY, Kim SH. Diabetes Metab J. 2015 Aug;39(4):316-20.
Women with rigorously managed overt diabetes during pregnancy do not experience adverse infant outcomes but do remain at serious risk of postpartum diabetes. Park S, Kim SH. Endocr J. 2015 Apr30; 62(4):319-27.